Correction: Age-Associated B Cell Features of the Murine High-Grade B Cell Lymphoma Bc.DLFL1 and Its Extranodal Expansion in Abdominal Adipose Tissues.
Journal of Immunology 2023 March 25
Jia, X., J. Bene, N. Balázs, K. Szabó, G. Berta, R. Herczeg, A. Gyenesei, and P. Balogh. 2022. Age-associated B cell features of the murine high-grade B cell lymphoma Bc.DLFL1 and its extranodal expansion in abdominal adipose tissues. J. Immunol. 208: 2866-2876. In the second sentence under the heading "IgVH region sequence of Bc.DLFL1 lymphoma reveals somatic hypermutation" in the Results section, there was an error in the listed mutations. In the list of non-silent mutations, "four mutations in CDR2 and CDR4 in FR3, respectively" should read "four mutations in CDR2 and FR3, respectively." The corrected sentence reads "We sequenced the V region amplified from cDNA, and the sequence alignment (30) with the germline mouse IgVH region (comprised of IgHV2-6-4*01/IgHD2-2*01/IgHJ*01 segments; GenBank accession no. MW191849; https://www.ncbi.nlm.nih.gov/nuccore/MW191849) revealed 11 non-silent mutations (two mutations in framework region 1 [FR1], one mutation in CDR1, and four mutations in CDR2 and FR3, respectively) and one silent mutation (in FR1), indicating a different VH region usage than reported among the most frequent recombinant variations for the ABC subset associated with systemic lupus erythematosus (40)." The sentence has been corrected in the online version of the article, which now differs from the print version as originally published.
Full text links
Trending Papers
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.Nature Reviews. Rheumatology 2023 May 10
A Systematic Approach to Understanding Acid-Base Disorders in the Critically Ill.Annals of Pharmacotherapy 2023 April 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app